25 May 2013
Keywords: synthelabo, signs, deal, texas, biotech, signed, collaborative
Article | 24 October 1994
Synthelabo has signed a collaborative agreement with Texas
Biotechnology Corp to codevelop and market compounds to prevent
reocclusion of blood ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
There are no related articles.
24 May 2013
© 2013 thepharmaletter.com